Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition

Abstract

The invention discloses traditional Chinese medicine composition for treating chronic pulmonary heart disease and a preparation method of the traditional Chinese medicine composition. The traditionalChinese medicine composition comprises traditional Chinese medicine raw materials in parts by weight as follows: 6-9 parts of herba ephedrae, 3-6 parts of herba asari, 10-15 parts of herba schizonepetae, 10-20 parts of radix saposhnikoviae, 10-20 parts of rhizoma zingiberis, 10-25 parts of fructus schisandrae, 20-30 parts of flos lonicerae, 10-15 parts of fructus forsythiae, 20-30 parts of gypsumfibrosum, 10-15 parts of radix scutellariae, 10-15 parts of cortex mori, 10-20 parts of rhizoma phragmitis, 10-15 parts of semen coicis, 8-15 parts of semen benincasae, 10-20 parts of semen armeniacaeamarum, 15-20 parts of radix scrophulariae, 10-15 parts of caulis bambusae in taenia and 6-10 parts of radix glycyrrhizae. The disclosed traditional Chinese medicine composition is reasonable in compatibility, has no toxic or side effects, has functions of moistening lung to arrest cough, reducing swelling, resolving mass, clearing away heat, purging pathogenic fire and dredging heart-lung, has agood curative effect on the chronic pulmonary heart disease and takes effect quickly, the course of treatment is short, and the disease is not prone to relapse.

Description

technical field [0001] The patent of the invention relates to, in particular, a traditional Chinese medicine composition for treating chronic cor pulmonale and a preparation method thereof, belonging to the field of traditional Chinese medicine. Background technique [0002] Chronic pulmonary heart disease (chronic pulmonary heart disease), referred to as chronic pulmonary heart disease (chronic corpulmonale), is caused by chronic lesions of lung tissue, pulmonary vessels or thorax, resulting in abnormal lung tissue structure and (or) function, resulting in increased pulmonary vascular resistance, Increased pulmonary artery pressure causes right ventricular dilatation (and) hypertrophy, heart disease with or without right heart failure, and excludes those caused by congenital heart disease and left heart disease. The disease develops slowly. Clinically, in addition to the various symptoms and signs of the original lung and chest diseases, the main signs of lung and heart fai...

AI Technical Summary

Problems solved by technology

[0013] The current method of treating chronic cor pulmonale generally uses drugs to control the disease, but the drug has a lot of side effects; in severe cases, surgery is used, but the risk of surgery is high